Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionTd Asset Management Inc
Latest Disclosed Ownership217,992 shares
Latest Disclosed Value $ 49,861,310
Td Asset Management Inc reports 6.85% decrease in ownership of ASND / Ascendis Pharma A/S

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 217,992 shares of Ascendis Pharma A/S (US:ASND) valued at $49,861,310 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 234,012 shares of Ascendis Pharma A/S. This represents a change in shares of -6.85% during the quarter. The current value of the position is $45,876,416 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 217,992 -16,020 -6.85 49,861 -0.08 0.0405
2026-02-10 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 234,012 -62,334 -21.03 49,901 -15.30 0.0401
2025-11-10 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 296,346 4,256 1.46 58,917 16.86 0.0478
2025-07-28 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 292,090 -51,300 -14.94 50,415 -5.80 0.0430
2025-05-07 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 343,390 3,738 1.10 53,521 14.46 0.0493
2025-02-11 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 339,652 86,528 34.18 46,760 27.74 0.0414
2024-11-01 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 253,124 153,178 153.26 36,607 168.57 0.0323
2024-08-02 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 99,946 -136,924 -57.81 13,631 -61.93 0.0127
2024-05-08 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 236,870 -7,708 -3.15 35,808 16.24 0.0333
2024-02-12 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 244,578 -22,782 -8.52 30,805 23.04 0.0303
2023-10-27 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 267,360 12,605 4.95 25,036 10.11 0.0303
2023-08-09 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 254,755 18,561 7.86 22,737 -10.22 0.0259
2023-05-10 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 236,194 39,894 20.32 25,325 5.63 0.0306
2023-02-07 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 196,300 64,700 49.16 23,974 77.52 0.0296
2022-11-07 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 131,600 24,629 23.02 13,505 35.81 0.0169
2022-08-04 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 106,971 -6,820 -5.99 9,944 -25.54 0.0115
2022-05-10 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 113,791 2,208 1.98 13,355 -11.03 0.0079
2022-02-10 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 111,583 20,948 23.11 15,011 3.91 0.0126
2021-11-09 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 90,635 13,814 17.98 14,446 59.11 0.0150
2021-08-11 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 76,821 -28,174 -26.83 9,079 -32.91 0.0092
2021-05-14 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 104,995 -21,786 -17.18 13,532 -36.00 0.0151
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 126,781 11,016 9.52 21,145 18.36 0.0257
2020-11-10 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 115,765 -3,440 -2.89 17,865 1.33 0.0248
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 119,205 4,801 4.20 17,630 36.85 0.0251
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 114,404 -7,800 -6.38 12,883 -24.22 0.0218
2020-02-11 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 122,204 -5,000 -3.93 17,001 38.76 0.0247
2019-11-07 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 127,204 12,836 11.22 12,252 -6.96 0.0187
2019-08-01 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 114,368 27,000 30.90 13,169 28.07 0.0197
2019-05-08 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 87,368 10,696 13.95 10,283 114.05 0.0157
2019-02-01 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 76,672 10,436 15.76 4,804 2.37 0.0084
2018-11-01 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 66,236 7,800 13.35 4,693 20.74 0.0069
2018-07-31 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 58,436 6,300 12.08 3,887 13.99 0.0059
2018-05-11 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 52,136 32,836 170.13 3,410 341.14 0.0052
2018-02-02 2017-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 19,300 19,300 773 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.